Trials / Conditions / Bardet-Biedl Syndrome

Bardet-Biedl Syndrome

13 registered clinical trials studyying Bardet-Biedl Syndrome — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Early Genetic Identification of Obesity NCT06239064	Rolfs Consulting und Verwaltungs-GmbH (RCV)	—
Completed	Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity NCT04966741	Rhythm Pharmaceuticals, Inc.	Phase 3
Completed	Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome NCT05400278	Oslo University Hospital	—
Completed	Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the NCT05194124	Rhythm Pharmaceuticals, Inc.	Phase 3
Unknown	Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) NCT04874909	Assistance Publique - Hôpitaux de Paris	N/A
Recruiting	COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Monocentric Interventional St NCT04461444	University Hospital, Strasbourg, France	N/A
Recruiting	GROWing Up With Rare GENEtic Syndromes NCT04463316	dr. Laura C. G. de Graaff-Herder	—
Withdrawn	Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement NCT03490019	University Hospital Tuebingen	Phase 2
Recruiting	Inherited Retinal Degenerative Disease Registry NCT02435940	Foundation Fighting Blindness	—
Recruiting	Clinical Registry Investigating Bardet-Biedl Syndrome NCT02329210	Marshfield Clinic Research Foundation	—
Recruiting	ARPKD Database Study NCT01401998	Children's Hospital of Philadelphia	—
Terminated	Genetics and Clinical Characteristics of Bardet-Biedl Syndrome NCT00078091	National Human Genome Research Institute (NHGRI)	—
Completed	Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults NCT00213811	University Hospital, Strasbourg, France	—